Types of research funded by Retina Australia
- Investigator-led research into inherited retinal disease, selected and approved via the Retina Australia Research Grants Program
- Other research projects that may be identified to meet industry need
2026 research grants
Retina Australia is delighted to announce two new Research Grant Recipients for 2026. These one-year projects are focused on finding potential new treatments for inherited retinal disease , and will commence in January 2026.
Development of epigenetic reprogramming technology to treat retinal degeneration
Associate Professor Raymond Wong - Centre for Eye Research Australia, University of Melbourne
$60,000
Selective Activation of Retinal Bipolar Cells Using Freeform Electrical Stimulation
Associate Professor Mohit Shivdasani - University of New South Wales
$57,912
2025 research grants
These grant projects are currently in progress and due to be completed by 31 December 2025.
Therapies for currently untreatable autosomal recessive IRDs
Professor Robyn Jamieson - Children's Medical Research Institute, Sydney Children’s Hospitals Network, Save Sight Institute - University of Sydney
$60,000
Advancing Usher syndrome type 1B gene therapy with split intein
Dr Jiang-Hui (Sloan) Wang - Centre for Eye Research Australia, Melbourne
$60,000
Research Impact Reports
Project summaries and impact reports of the past recipients awarded by the Retina Australia Grants Program can be found here.
Characterizing Stargardt Disease Mutations for Splice Intervention Therapeutics
Dr Di Huang - Lions Eye Institute
$60,000 (2024, co-funded by the Perth Eye Foundation)
Virtual Reality Assessment of Functional Vision in achromatopsia
Dr Elisa Cornish - Save Sight Institute, Sydney
$52,639 (2024)
Establishing novel AAV gene editing for Usher Syndrome
Dr Anai Gonzalez-Cordero - Children’s Medical Research Institute, Sydney
$55,774 (2023)
Using RNA-silencing to tackle neuroinflammation in retinal degeneration
Dr Adrian Cioanca - John Curtin School of Medical Research, Canberra
$59,869 (2023)